Study to Evaluate the ECG Effects of Telaglenastat in Healthy Adult Subjects

NCT04607512 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiac Safety

Interventions

DRUG: telaglenastat
OTHER: telaglenastat placebo
OTHER: moxifloxicin

Sponsor

Calithera Biosciences, Inc